INTRACELLULAR TARGETING OF EXOENZYME-S OF PSEUDOMONAS-AERUGINOSA VIA TYPE-III-DEPENDENT TRANSLOCATION INDUCES PHAGOCYTOSIS RESISTANCE, CYTOTOXICITY AND DISRUPTION OF ACTIN MICROFILAMENTS
E. Frithzlindsten et al., INTRACELLULAR TARGETING OF EXOENZYME-S OF PSEUDOMONAS-AERUGINOSA VIA TYPE-III-DEPENDENT TRANSLOCATION INDUCES PHAGOCYTOSIS RESISTANCE, CYTOTOXICITY AND DISRUPTION OF ACTIN MICROFILAMENTS, Molecular microbiology, 25(6), 1997, pp. 1125-1139
Exoenzyme S (ExoS) is an ADP-ribosyltransferase secreted by the opport
unistic pathogen Pseudomonas aeruginosa. The amino-terminal half of Ex
oS exhibits homology to the YopE cytotoxin of pathogenic Yersinia. Rec
ently, YopE was found to be translocated into the host cell by a bacte
ria-cell contact-dependent mechanism involving the ysc-encoded type II
I secretion system, By using an approach in which exoS was expressed i
n different strains of Yersinia, including secretion and translocation
mutants, we could demonstrate that ExoS was secreted and translocated
into HeLa cells by a similar mechanism to that described previously f
or YopE, Similarly to YopE, the presence of ExoS in the host cell elic
ited a cytotoxic response, correlating with disruption of the actin mi
crofilament structure. A similar cytotoxic response was also induced b
y a mutated form of ExoS with a more than 2000-fold reduced ADP-ribosy
ltransferase activity. However, the enzymatically active ExoS elicited
a more definite rounding up of the HeLa cells, which also correlated
with decreased Viability of the cells after prolonged infection compar
ed with cells infected with strains expressing mutated ExoS or YopE. T
his suggests that ExoS can act through two different mechanisms on the
host cell, The expression of ExoS by Yersinia also mediated an anti-p
hagocytic effect on macrophages. In addition, we present evidence that
extracellularly located P. aeruginosa is able to target ExoS into euk
aryotic cells. Taken together, our data suggest that P. aeruginosa, by
analogy with Yersinia, targets virulence proteins into the eukaryotic
cytosol via a type III secretion-dependent mechanism as part of an an
ti-phagocytic strategy.